tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
US Market

Lineage Therap (LCTX) Income Statement

Compare
2,048 Followers

Lineage Therap Income Statement

Last quarter (Q4 2025), Lineage Therap's total revenue was $6.61M, an increase of 130.40% from the same quarter last year. In Q4, Lineage Therap's net income was $851.00K. See Lineage Therap’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 14.56M$ 9.50M$ 8.95M$ 14.70M$ 3.90M
Gross Profit
$ 13.71M$ 9.16M$ 8.27M$ 13.97M$ 2.47M
Operating Expenses
$ 35.49M$ 30.64M$ 33.01M$ 36.49M$ 51.68M
Depreciation and Amortization
$ 699.00K$ 609.00K$ 692.00K$ 727.00K$ 873.00K
EBITDA
$ -21.08M$ -20.87M$ -24.04M$ -21.79M$ -48.34M
Operating Income
$ -21.78M$ -21.48M$ -24.73M$ -22.52M$ -49.21M
Other Income/Expenses
$ -46.87M$ 2.90M$ 1.45M$ -3.29M$ 5.94M
Pretax Income
$ -68.65M$ -18.58M$ -23.28M$ -25.81M$ -43.27M
Net Income
$ -63.53M$ -18.61M$ -21.49M$ -26.27M$ -43.02M
Per Share Metrics
Basic EPS
$ -0.28$ -0.09$ -0.12$ -0.15$ -0.26
Diluted EPS
$ -0.28$ -0.09$ -0.12$ -0.15$ -0.26
Weighted Average Shares Outstanding
230.12M 200.19M 172.66M 169.79M 164.50M
Weighted Average Shares Outstanding (Diluted)
230.12M 200.19M 172.66M 169.79M 164.50M
Currency in USD

Lineage Therap Earnings and Revenue History